Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period of 2024, representing an increase of $0.3 million, primarily attributable to ...

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can also trigger ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

By studying Chikungunya virus, scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease.

MIT researchers found a way to measure cell density quickly and accurately — measuring up to 30,000 cells in a single hour. They also showed density changes could be used to make useful predictions, ...

As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing immune cells.

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

Sunshine may hold healing rays for a variety of autoimmune diseases such as multiple sclerosis. Scientists are turning this ...

Measuring the density of a cell can reveal a great deal about the cell's state. As cells proliferate, differentiate, or ...

Oncolytic viruses trigger immunogenic cell death in tumors, releasing signals that activate innate immune cells and promote tumor-specific T-cell responses. While some oncolytic viruses, including FDA ...